FIELD: medicine, narcology. SUBSTANCE: invention proposes to use myelopid for treatment of drug addicts. Agent helps to overcome the attraction to narcotic and improves psychoemotional state of patients. EFFECT: enhanced effectiveness of agent. 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD TO CORRECT IMMUNE DISORDERS AT OPIUM NARCOMANIA | 2000 |
|
RU2183125C1 |
METHOD FOR CORRECTION OF IMMUNE DISTURBANCE IN OPIUM NARCOMANIA | 2003 |
|
RU2254128C2 |
METHOD FOR TREATING OPIUM NARCOMANIA | 2005 |
|
RU2290947C1 |
AGENT FOR CORRECTION OF SLEEP DISORDER IN DRUG ADDICTS | 2000 |
|
RU2162325C1 |
METHOD FOR EVALUATING STATE OF HUMAN ENDOGENIC OPIOID SYSTEM | 2001 |
|
RU2199942C2 |
METHOD OF HEROINE ADDICTION TREATMENT | 2006 |
|
RU2344822C2 |
METHOD OF OPIUM NARCOMANIA TREATMENT | 1999 |
|
RU2192275C2 |
MEANS FOR TREATING AND PREVENTING NARCOMANIA | 2001 |
|
RU2188630C1 |
METHOD OF PREVENTING RECURRENCES OF OPIUM ADDICTION | 2010 |
|
RU2428123C1 |
AGENT FOR TREATMENT OF COMPULSIVE INCLINATION TO NARCOTIC-OPIATE | 1997 |
|
RU2152799C1 |
Authors
Dates
2001-01-27—Published
2000-03-20—Filed